Home/GABAeron/Robert W. Mahley, MD, PhD

RW

Robert W. Mahley, MD, PhD

Chief Executive Officer & Chief Scientific Officer

Therapeutic Areas

Alzheimer's Disease Neurodegenerative Disorders Neurodevelopmental Disorders

GABAeron Pipeline

Drug	Indication	Phase
Neuron Replacement Therapy for apoE4 Carriers	Alzheimer's Disease & Other Neurodegenerative Disorders	Pre-clinical

Leadership Team at GABAeron

Senior Director of Technology / Discovery

Yadong Huang, MD, PhD

Scientific Co-Founder

Sheng Ding, PhD

Scientific Co-Founder

View full GABAeron profile